Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
12,664
Value
$4.55M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,664$4.55M<0.1%+121+1.0%AddedHolders
Q1 202612,543$3.14M<0.1%+1,641+15.1%AddedHolders
Q4 202510,902$3.00M<0.1%+652+6.4%AddedHolders
Q3 202510,250$2.69M<0.1%−438−4.1%ReducedHolders
Q2 202510,688$2.34M<0.1%−3,624−25.3%ReducedHolders
Q1 202514,312$3.20M<0.1%−390−2.7%ReducedHolders
Q4 202414,702$4.82M<0.1%−2,056−12.3%ReducedHolders
Q3 202416,758$5.03M<0.1%+2,667+18.9%AddedHolders
Q2 202414,091$4.64M<0.1%−2,962−17.4%ReducedHolders
Q1 202417,053$6.75M0.1%+483+2.9%AddedHolders
Q4 202316,570$5.83M0.1%−829−4.8%ReducedHolders
Q3 202317,399$6.53M0.1%+297+1.7%AddedHolders
Q2 202317,102$6.54M0.1%+204+1.2%AddedHolders
Q1 202316,898$5.85M0.1%−373−2.2%ReducedHolders
Q4 202217,271$4.06M0.1%+2,248+15.0%AddedHolders
Q3 202215,023$3.70M0.1%+1,049+7.5%AddedHolders
Q2 202213,974$4.22M0.1%+1,300+10.3%AddedHolders
Q1 202212,674$5.21M0.1%−7,725−37.9%ReducedHolders
Q4 202120,399$9.57M0.2%−7,113−25.9%ReducedHolders
Q3 202127,512$11.7M0.2%−419−1.5%ReducedHolders
Q2 202127,931$10.0M0.2%+17,122+158.4%AddedHolders
Q1 202110,809$3.05M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.